# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...
Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target ...
Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target from $90 to ...
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.69 per share which beat the analyst consensus estimate of $1....